The DarT/DarG Toxin–Antitoxin ADP-Ribosylation System as a Novel Target for a Rational Design of Innovative Antimicrobial Strategies

The chemical modification of cellular macromolecules by the transfer of ADP-ribose unit(s), known as ADP-ribosylation, is an ancient homeostatic and stress response control system. Highly conserved across the evolution, ADP-ribosyltransferases and ADP-ribosylhydrolases control ADP-ribosylation signalling and cellular responses. In addition to proteins, both prokaryotic and eukaryotic transferases can covalently link ADP-ribosylation to different conformations of nucleic acids, thus highlighting the evolutionary conservation of archaic stress response mechanisms. Here, we report several structural and functional aspects of DNA ADP-ribosylation modification controlled by the prototype DarT and DarG pair, which show ADP-ribosyltransferase and hydrolase activity, respectively. DarT/DarG is a toxin–antitoxin system conserved in many bacterial pathogens, for example in Mycobacterium tuberculosis, which regulates two clinically important processes for human health, namely, growth control and the anti-phage response. The chemical modulation of the DarT/DarG system by selective inhibitors may thus represent an exciting strategy to tackle resistance to current antimicrobial therapies.

[1]  A. Zasada,et al.  New Corynebacterium Species with the Potential to Produce Diphtheria Toxin , 2022, Pathogens.

[2]  I. Dikic,et al.  An expanded lexicon for the ubiquitin code , 2022, Nature reviews. Molecular cell biology.

[3]  Haoming Xu,et al.  Current Status of Phage Therapy against Infectious Diseases and Potential Application beyond Infectious Diseases , 2022, International journal of clinical practice.

[4]  Marc Torrent Burgas,et al.  Analysis of Host–Bacteria Protein Interactions Reveals Conserved Domains and Motifs That Mediate Fundamental Infection Pathways , 2022, International journal of molecular sciences.

[5]  L. Aravind,et al.  Apprehending the NAD+–ADPr-Dependent Systems in the Virus World , 2022, Viruses.

[6]  C. Niehrs,et al.  Mammalian N1-adenosine PARylation is a reversible DNA modification , 2022, bioRxiv.

[7]  I. Ahel,et al.  Streptomyces coelicolor macrodomain hydrolase SCO6735 cleaves thymidine-linked ADP-ribosylation of DNA , 2022, Computational and structural biotechnology journal.

[8]  X. Jiao,et al.  Toxin-antitoxin systems: Classification, biological roles, and applications. , 2022, Microbiological research.

[9]  Yurii S. Moroz,et al.  Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 Macrodomain of SARS-CoV-2 , 2022, bioRxiv.

[10]  G. Zeller,et al.  Bacterial retrons encode phage-defending tripartite toxin–antitoxin systems , 2022, Nature.

[11]  H. Oschkinat,et al.  Mechanism of threonine ADP-ribosylation of F-actin by a Tc toxin , 2022, Nature Communications.

[12]  U. Baumann,et al.  TIR-catalyzed ADP-ribosylation reactions produce signaling molecules for plant immunity , 2022, bioRxiv.

[13]  W. Kraus,et al.  Multiomics analysis of the NAD+–PARP1 axis reveals a role for site-specific ADP-ribosylation in splicing in embryonic stem cells , 2022, Genes & development.

[14]  Peter R. McDonald,et al.  Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening , 2022, Antiviral Research.

[15]  Anthony R. Fehr,et al.  Design, synthesis and evaluation of inhibitors of the SARS-CoV-2 nsp3 macrodomain , 2022, Bioorganic & Medicinal Chemistry.

[16]  M. Laub,et al.  Toxin-Antitoxin Systems as Phage Defense Elements. , 2022, Annual review of microbiology.

[17]  G. Manco,et al.  ADP-Ribosylation Post-Translational Modification: An Overview with a Focus on RNA Biology and New Pharmacological Perspectives , 2022, Biomolecules.

[18]  I. Ahel,et al.  Beyond protein modification: the rise of non-canonical ADP-ribosylation , 2022, The Biochemical journal.

[19]  A. Emili,et al.  Neuralized-like protein 4 (NEURL4) mediates ADP-ribosylation of mitochondrial proteins , 2022, The Journal of cell biology.

[20]  D. Sinclair,et al.  NAD+ in COVID-19 and viral infections , 2022, Trends in Immunology.

[21]  R. Sorek,et al.  SnapShot: Bacterial immunity , 2022, Cell.

[22]  L. Van Melderen,et al.  Biology and evolution of bacterial toxin–antitoxin systems , 2022, Nature Reviews Microbiology.

[23]  Anthony R. Fehr,et al.  The Conserved Macrodomain Is a Potential Therapeutic Target for Coronaviruses and Alphaviruses , 2022, Pathogens.

[24]  T. Zhang,et al.  The DarTG toxin-antitoxin system provides phage defence by ADP-ribosylating viral DNA , 2021, Nature Microbiology.

[25]  M. Touchon,et al.  Systematic and quantitative view of the antiviral arsenal of prokaryotes , 2021, Nature Communications.

[26]  T. Ottenhoff,et al.  Pharmacological Poly (ADP-Ribose) Polymerase Inhibitors Decrease Mycobacterium tuberculosis Survival in Human Macrophages , 2021, Frontiers in Immunology.

[27]  M. Khurshid,et al.  Antibiotic Resistance: One Health One World Outlook , 2021, Frontiers in Cellular and Infection Microbiology.

[28]  I. Ahel,et al.  The Making and Breaking of Serine-ADP-Ribosylation in the DNA Damage Response , 2021, Frontiers in Cell and Developmental Biology.

[29]  A. Jayabalan,et al.  High-Throughput Activity Assay for Screening Inhibitors of the SARS-CoV-2 Mac1 Macrodomain , 2021, bioRxiv.

[30]  I. Ahel,et al.  Noncanonical mono(ADP-ribosyl)ation of zinc finger SZF proteins counteracts ubiquitination for protein homeostasis in plant immunity. , 2021, Molecular cell.

[31]  M. Lopes,et al.  TARG1 protects against toxic DNA ADP-ribosylation , 2021, Nucleic acids research.

[32]  I. Ahel,et al.  Molecular basis for DarT ADP-ribosylation of a DNA base , 2021, Nature.

[33]  A. Bruni-Cardoso,et al.  The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signaling , 2021, Journal of Biological Chemistry.

[34]  Yan Peng,et al.  Ribosome ADP-ribosylation inhibits translation and maintains proteostasis in cancers , 2021, Cell.

[35]  Mohit Yadav,et al.  Bacterial toxin-antitoxin modules: classification, functions, and association with persistence , 2021, Current research in microbial sciences.

[36]  S. Salcedo,et al.  NAD+-targeting by bacteria: an emerging weapon in pathogenesis. , 2021, FEMS microbiology reviews.

[37]  W. Kraus,et al.  Nuclear ADP-ribosylation drives IFNγ-dependent STAT1α enhancer formation in macrophages , 2021, Nature Communications.

[38]  I. Ahel,et al.  ADP-ribosylation of DNA and RNA , 2021, DNA repair.

[39]  F. Martínez-Abarca,et al.  Prokaryotic reverse transcriptases: from retroelements to specialized defense systems , 2021, FEMS microbiology reviews.

[40]  L. Virág,et al.  The PARP Enzyme Family and the Hallmarks of Cancer Part 1. Cell Intrinsic Hallmarks , 2021, Cancers.

[41]  I. Ahel,et al.  ADP-ribosylation systems in bacteria and viruses , 2021, Computational and structural biotechnology journal.

[42]  A. Ashworth,et al.  Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking , 2021, Science Advances.

[43]  B. Lüscher,et al.  ADP-ribosylation of RNA and DNA: from in vitro characterization to in vivo function , 2021, Nucleic acids research.

[44]  S. Pati,et al.  Toxin-antitoxin systems and their medical applications: current status and future perspective , 2021, Applied Microbiology and Biotechnology.

[45]  Anna Barnard,et al.  Modulators of protein–protein interactions as antimicrobial agents , 2021, RSC chemical biology.

[46]  Yong-Xing He,et al.  Bacterial type II toxin-antitoxin systems acting through post-translational modifications , 2020, Computational and structural biotechnology journal.

[47]  I. Matic,et al.  Serine-ubiquitination regulates Golgi morphology and the secretory pathway upon Legionella infection , 2020, Cell Death & Differentiation.

[48]  M. R. Lugo,et al.  Development of Anti-Virulence Therapeutics against Mono-ADP-Ribosyltransferase Toxins , 2020, Toxins.

[49]  I. Ahel,et al.  Viral macrodomains: a structural and evolutionary assessment of the pharmacological potential , 2020, Open Biology.

[50]  N. Curtin,et al.  Poly(ADP-ribose) polymerase inhibition: past, present and future , 2020, Nature reviews. Drug discovery.

[51]  N. El-Dougdoug,et al.  Controlling foodborne pathogens with natural antimicrobials by biological control and antivirulence strategies , 2020, Heliyon.

[52]  J. Trylska,et al.  Targeting Type II Toxin–Antitoxin Systems as Antibacterial Strategies , 2020, Toxins.

[53]  T. Wood,et al.  A Primary Physiological Role of Toxin/Antitoxin Systems Is Phage Inhibition , 2020, Frontiers in Microbiology.

[54]  Yonghao Yu,et al.  PARP1 inhibitors trigger innate immunity via PARP1 trapping-induced DNA damage response , 2020, bioRxiv.

[55]  Linnan Zhu,et al.  Depletion of the DarG antitoxin in Mycobacterium tuberculosis triggers the DNA‐damage response and leads to cell death , 2020, Molecular microbiology.

[56]  R. Sorek,et al.  Bacterial Retrons Function In Anti-Phage Defense , 2020, Cell.

[57]  R. Sorek,et al.  Abortive Infection: Bacterial Suicide as an Antiviral Immune Strategy. , 2020, Annual review of virology.

[58]  Anthony R. Fehr,et al.  The Viral Macrodomain Counters Host Antiviral ADP-Ribosylation , 2020, Viruses.

[59]  K. Lewis.  The Science of Antibiotic Discovery , 2020, Cell.

[60]  A. Ishchenko,et al.  Insight into DNA substrate specificity of PARP1-catalysed DNA poly(ADP-ribosyl)ation , 2020, Scientific Reports.

[61]  A. Ishchenko,et al.  Insight into DNA substrate specificity of PARP1-catalysed DNA poly(ADP-ribosyl)ation , 2020, Scientific Reports.

[62]  D. Slade.  PARP and PARG inhibitors in cancer treatment. , 2020, Genes & development.

[63]  Anthony R. Fehr,et al.  The impact of PARPs and ADP-ribosylation on inflammation and host–pathogen interactions , 2020, Genes & development.

[64]  I. Ahel,et al.  (ADP-ribosyl)hydrolases: structure, function, and biology , 2020, Genes & development.

[65]  I. Ahel,et al.  HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation , 2020, Nature.

[66]  L. Van Melderen,et al.  Type II Toxin-Antitoxin Systems: Evolution and Revolutions , 2020, Journal of bacteriology.

[67]  Stephan Uphoff,et al.  DNA ADP-Ribosylation Stalls Replication and Is Reversed by RecF-Mediated Homologous Recombination and Nucleotide Excision Repair , 2019, Cell reports.

[68]  R. Laxminarayan,et al.  Antibiotic development — economic, regulatory and societal challenges , 2019, Nature Reviews Microbiology.

[69]  Jianzhong Shen,et al.  Natural products that target virulence factors in antibiotic resistant Staphylococcus aureus. , 2019, Journal of agricultural and food chemistry.

[70]  R. Sorek,et al.  The pan-immune system of bacteria: antiviral defence as a community resource , 2019, Nature Reviews Microbiology.

[71]  Eirini Christaki,et al.  Antimicrobial Resistance in Bacteria: Mechanisms, Evolution, and Persistence , 2019, Journal of Molecular Evolution.

[72]  V. Malladi,et al.  Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21. , 2019, Molecular cell.

[73]  Cong Liu,et al.  New insights of poly(ADP-ribosylation) in neurodegenerative diseases: A focus on protein phase separation and pathologic aggregation. , 2019, Biochemical pharmacology.

[74]  Z. Deng,et al.  Toxin–antitoxin operon kacAT of Klebsiella pneumoniae is regulated by conditional cooperativity via a W-shaped KacA–KacT complex , 2019, Nucleic acids research.

[75]  R. Mukherjee,et al.  Ameliorating the antimicrobial resistance crisis: phage therapy , 2019, IUBMB life.

[76]  B. Maček,et al.  Serine-Threonine Kinases Encoded by Split hipA Homologs Inhibit Tryptophanyl-tRNA Synthetase , 2019, mBio.

[77]  G. Grimaldi,et al.  Targeting ADP-ribosylation as an antimicrobial strategy , 2019, Biochemical Pharmacology.

[78]  S. Perlman,et al.  The coronavirus macrodomain is required to prevent PARP-mediated inhibition of virus replication and enhancement of IFN expression , 2019, PLoS pathogens.

[79]  Michael S. Cohen,et al.  Reversible ADP-ribosylation of RNA , 2019, Nucleic acids research.

[80]  Chun-Hua Hsu,et al.  Structural and biochemical evidence supporting poly ADP-ribosylation in the bacterium Deinococcus radiodurans , 2019, Nature Communications.

[81]  Laurent Falquet,et al.  TASmania: A bacterial Toxin-Antitoxin Systems database , 2019, PLoS Comput. Biol..

[82]  I. Ahel,et al.  ADP-ribosylation signalling and human disease , 2019, Open Biology.

[83]  D. Svergun,et al.  An NAD+ Phosphorylase Toxin Triggers Mycobacterium tuberculosis Cell Death , 2019, Molecular cell.

[84]  P. Jeffrey,et al.  ParST is a widespread toxin–antitoxin module that targets nucleotide metabolism , 2018, Proceedings of the National Academy of Sciences.

[85]  C. Stålsby Lundborg,et al.  Drivers of Irrational Use of Antibiotics in Europe , 2018, International journal of environmental research and public health.

[86]  L. Carro.  Protein–protein interactions in bacteria: a promising and challenging avenue towards the discovery of new antibiotics , 2018, Beilstein journal of organic chemistry.

[87]  I. Ahel,et al.  PARPs in genome stability and signal transduction: implications for cancer therapy , 2018, Biochemical Society transactions.

[88]  Paul A. Wiggins,et al.  Bifunctional Immunity Proteins Protect Bacteria against FtsZ-Targeting ADP-Ribosylating Toxins , 2018, Cell.

[89]  Michael S. Cohen,et al.  ADP-ribosyl–binding and hydrolase activities of the alphavirus nsP3 macrodomain are critical for initiation of virus replication , 2018, Proceedings of the National Academy of Sciences.

[90]  Younghoon Lee,et al.  The small RNA, SdsR, acts as a novel type of toxin in Escherichia coli , 2018, RNA biology.

[91]  H. Tsuge,et al.  Substrate N2 atom recognition mechanism in pierisin family DNA-targeting, guanine-specific ADP-ribosyltransferase ScARP , 2018, The Journal of Biological Chemistry.

[92]  P. Lewis,et al.  Protein‐protein interactions as antibiotic targets: A medicinal chemistry perspective , 2018, Medicinal research reviews.

[93]  Y. Wolf,et al.  Escherichia coli ItaT is a type II toxin that inhibits translation by acetylating isoleucyl-tRNAIle , 2018, Nucleic acids research.

[94]  D. Brodersen,et al.  Toxins, Targets, and Triggers: An Overview of Toxin-Antitoxin Biology. , 2018, Molecular cell.

[95]  José F. Hidalgo,et al.  Comparative inhibitory profile and distribution of bacterial PARPs, using Clostridioides difficile CD160 PARP as a model , 2018, Scientific Reports.

[96]  Donghyuk Shin,et al.  Insights into catalysis and function of phosphoribosyl-linked serine ubiquitination , 2018, Nature.

[97]  D. J. Wasilko,et al.  The mechanism of phosphoribosyl-ubiquitination mediated by a single Legionella effector , 2018, Nature.

[98]  O. Lavrik,et al.  Dna is a New Target of Parp3 , 2018, Scientific Reports.

[99]  D. Griffin,et al.  Macrodomain ADP-ribosylhydrolase and the pathogenesis of infectious diseases , 2018, PLoS pathogens.

[100]  B. E. Black,et al.  NAD+ analog reveals PARP-1 substrate-blocking mechanism and allosteric communication from catalytic center to DNA-binding domains , 2018, Nature Communications.

[101]  I. Matic,et al.  Serine is the major residue for ADP-ribosylation upon DNA damage , 2018, eLife.

[102]  Michael S. Cohen,et al.  Insights into the biogenesis, function, and regulation of ADP-ribosylation. , 2018, Nature chemical biology.

[103]  D. Biard,et al.  Characterization of DNA ADP-ribosyltransferase activities of PARP2 and PARP3: new insights into DNA ADP-ribosylation , 2018, Nucleic acids research.

[104]  S. Perlman,et al.  Viral Macrodomains: Unique Mediators of Viral Replication and Pathogenesis , 2017, Trends in Microbiology.

[105]  B. Lüscher,et al.  ADP-Ribosylation, a Multifaceted Posttranslational Modification Involved in the Control of Cell Physiology in Health and Disease. , 2017, Chemical reviews.

[106]  H. Schüler,et al.  Structure-activity relationships for inhibitors of Pseudomonas aeruginosa exoenzyme S ADP-ribosyltransferase activity. , 2018, European journal of medicinal chemistry.

[107]  Zhao‐Qing Luo,et al.  Hijacking of the Host Ubiquitin Network by Legionella pneumophila , 2017, Front. Cell. Infect. Microbiol..

[108]  I. Ahel,et al.  Reversible mono‐ADP‐ribosylation of DNA breaks , 2017, The FEBS journal.

[109]  D. Corda,et al.  PARP1-produced poly-ADP-ribose causes the PARP12 translocation to stress granules and impairment of Golgi complex functions , 2017, Scientific Reports.

[110]  Maxime Québatte,et al.  A bacterial toxin-antitoxin module is the origin of inter-bacterial and inter-kingdom effectors of Bartonella , 2017, PLoS genetics.

[111]  L. Van Melderen,et al.  Novel toxins from type II toxin-antitoxin systems with acetyltransferase activity. , 2017, Plasmid.

[112]  I. Ahel,et al.  ADP‐ribosylation: new facets of an ancient modification , 2017, The FEBS journal.

[113]  Alan Ashworth,et al.  PARP inhibitors: Synthetic lethality in the clinic , 2017, Science.

[114]  Timothy R. Walsh,et al.  Toxin–antitoxin systems and their role in disseminating and maintaining antimicrobial resistance , 2017, FEMS microbiology reviews.

[115]  I. Matic,et al.  Serine ADP-Ribosylation Depends on HPF1 , 2017, Molecular cell.

[116]  H. Tsuge,et al.  Crystal structure and structure-based mutagenesis of actin-specific ADP-ribosylating toxin CPILE-a as novel enterotoxin , 2017, PloS one.

[117]  G. Rossetti,et al.  The conserved macrodomains of the non-structural proteins of Chikungunya virus and other pathogenic positive strand RNA viruses function as mono-ADP-ribosylhydrolases , 2017, Scientific Reports.

[118]  Ziying Liu,et al.  PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes , 2017, Genes & development.

[119]  I. Ahel,et al.  The Toxin-Antitoxin System DarTG Catalyzes Reversible ADP-Ribosylation of DNA , 2016, Molecular cell.

[120]  Jincun Zhao,et al.  The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection , 2016, mBio.

[121]  M. Mayzel,et al.  An oxygen-sensitive toxin–antitoxin system , 2016, Nature Communications.

[122]  P. He,et al.  Protein ADP-Ribosylation Takes Control in Plant–Bacterium Interactions , 2016, PLoS pathogens.

[123]  J. Briggs,et al.  Inhibition of Cholera Toxin and Other AB Toxins by Polyphenolic Compounds , 2016, PloS one.

[124]  I. Matic,et al.  Disruption of Macrodomain Protein SCO6735 Increases Antibiotic Production in Streptomyces coelicolor* , 2016, The Journal of Biological Chemistry.

[125]  Paramjit S Arora,et al.  Systematic Targeting of Protein-Protein Interactions. , 2016, Trends in pharmacological sciences.

[126]  D. Gasparutto,et al.  Poly(ADP-ribose) polymerases covalently modify strand break termini in DNA fragments in vitro , 2016, Nucleic acids research.

[127]  Anastasia Mylona,et al.  A Salmonella Toxin Promotes Persister Formation through Acetylation of tRNA , 2016, Molecular cell.

[128]  Yonghao Yu,et al.  Chemical genetic discovery of PARP targets reveals a role for PARP-1 in transcription elongation , 2016, Science.

[129]  I. Ahel,et al.  Macrodomains: Structure, Function, Evolution, and Catalytic Activities. , 2016, Annual review of biochemistry.

[130]  S. Bhogaraju,et al.  Cell biology: Ubiquitination without E1 and E2 enzymes , 2016, Nature.

[131]  D. Scott,et al.  Small molecules, big targets: drug discovery faces the protein–protein interaction challenge , 2016, Nature Reviews Drug Discovery.

[132]  Rebecca Page,et al.  Toxin-antitoxin systems in bacterial growth arrest and persistence. , 2016, Nature chemical biology.

[133]  M. R. Lugo,et al.  Scabin, a Novel DNA-acting ADP-ribosyltransferase from Streptomyces scabies* , 2016, The Journal of Biological Chemistry.

[134]  I. Dikic,et al.  Bacteria-host relationship: ubiquitin ligases as weapons of invasion , 2016, Cell Research.

[135]  H. Schüler,et al.  Identification of Inhibitors of Pseudomonas aeruginosa Exotoxin-S ADP-Ribosyltransferase Activity , 2016, Journal of biomolecular screening.

[136]  I. Henderson,et al.  Alternatives to antibiotics-a pipeline portfolio review. , 2016, The Lancet. Infectious diseases.

[137]  E. Nakayasu,et al.  Identification of Fic-1 as an enzyme that inhibits bacterial DNA replication by AMPylating GyrB, promoting filament formation , 2016, Science Signaling.

[138]  J. Estaquier,et al.  Exploring NAD+ metabolism in host–pathogen interactions , 2016, Cellular and Molecular Life Sciences.

[139]  J. Zang,et al.  Structural insights into the mechanism of Escherichia coli YmdB: A 2'-O-acetyl-ADP-ribose deacetylase. , 2015, Journal of structural biology.

[140]  M. Holtzman,et al.  PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection , 2015, Nature Immunology.

[141]  K. Gerdes,et al.  Adenylylation of Gyrase and Topo IV by FicT Toxins Disrupts Bacterial DNA Topology. , 2015, Cell reports.

[142]  I. Matic,et al.  Identification of a Class of Protein ADP-Ribosylating Sirtuins in Microbial Pathogens , 2015, Molecular cell.

[143]  F. Winkler,et al.  Regulation of nitrogenase by reversible mono-ADP-ribosylation. , 2015, Current topics in microbiology and immunology.

[144]  Masahiko Watanabe,et al.  Pierisins and CARP-1: ADP-ribosylation of DNA by ARTCs in butterflies and shellfish. , 2015, Current topics in microbiology and immunology.

[145]  L. Aravind,et al.  The natural history of ADP-ribosyltransferases and the ADP-ribosylation system. , 2015, Current topics in microbiology and immunology.

[146]  I. Ahel,et al.  Distribution of protein poly(ADP-ribosyl)ation systems across all domains of life , 2014, DNA repair.

[147]  Klaus Aktories,et al.  Novel bacterial ADP-ribosylating toxins: structure and function , 2014, Nature Reviews Microbiology.

[148]  I. Matic,et al.  Family-wide analysis of poly(ADP-ribose) polymerase activity , 2014, Nature Communications.

[149]  P. Hassa,et al.  DTX3L and ARTD9 inhibit IRF1 expression and mediate in cooperation with ARTD8 survival and proliferation of metastatic prostate cancer cells , 2014, Molecular Cancer.

[150]  C. Sasakawa,et al.  Exploitation of the host ubiquitin system by human bacterial pathogens , 2014, Nature Reviews Microbiology.

[151]  B. Devreese,et al.  Toxin-Antitoxin systems: their role in persistence, biofilm formation, and pathogenicity. , 2014, Pathogens and disease.

[152]  Peter C. Fineran,et al.  A widespread bacteriophage abortive infection system functions through a Type IV toxin–antitoxin mechanism , 2014, Nucleic acids research.

[153]  E. Rotem,et al.  HipA-mediated antibiotic persistence via phosphorylation of the glutamyl-tRNA-synthetase , 2013, Nature Communications.

[154]  S. Wickner,et al.  Preventing bacterial suicide: a novel toxin-antitoxin strategy. , 2013, Molecular cell.

[155]  E. Frolova,et al.  Interferon-Stimulated Poly(ADP-Ribose) Polymerases Are Potent Inhibitors of Cellular Translation and Virus Replication , 2013, Journal of Virology.

[156]  N. Zenkin,et al.  Molecular mechanism of bacterial persistence by HipA. , 2013, Molecular cell.

[157]  A. Garcia-Pino,et al.  The Fic protein Doc uses an inverted substrate to phosphorylate and inactivate EF-Tu , 2013, Nature chemical biology.

[158]  Wilfried Rozhon,et al.  Toxin–antitoxin systems , 2013, Mobile genetic elements.

[159]  M. Högbom,et al.  ADP‐ribosylation, a mechanism regulating nitrogenase activity , 2013, The FEBS journal.

[160]  Bong‐Jin Lee,et al.  Structural overview of toxin-antitoxin systems in infectious bacteria: a target for developing antimicrobial agents. , 2013, Biochimica et biophysica acta.

[161]  I. Matic,et al.  Deficiency of terminal ADP‐ribose protein glycohydrolase TARG1/C6orf130 in neurodegenerative disease , 2013, The EMBO journal.

[162]  Masafumi Yamamoto,et al.  ADP-ribosylation of guanosine by SCO5461 protein secreted from Streptomyces coelicolor. , 2013, Toxicon : official journal of the International Society on Toxinology.

[163]  Sylvain Moineau,et al.  Structure and activity of AbiQ, a lactococcal endoribonuclease belonging to the type III toxin–antitoxin system , 2013, Molecular microbiology.

[164]  Torsten Herrmann,et al.  A Novel Type V TA System Where mRNA for Toxin GhoT is Cleaved by Antitoxin GhoS , 2012, Nature chemical biology.

[165]  V. Schreiber,et al.  The diverse roles and clinical relevance of PARPs in DNA damage repair: current state of the art. , 2012, Biochemical pharmacology.

[166]  J. Keserű,et al.  Disruption of SCO5461 gene coding for a mono-ADP-ribosyltransferase enzyme produces a conditional pleiotropic phenotype affecting morphological differentiation and antibiotic production in Streptomyces coelicolor , 2012, Journal of Microbiology.

[167]  J. Keserű,et al.  Disruption of SCO5461 gene coding for a mono-ADP-ribosyltransferase enzyme produces a conditional pleiotropic phenotype affecting morphological differentiation and antibiotic production in Streptomyces coelicolor , 2012, Journal of Microbiology.

[168]  M. Inouye,et al.  YeeU enhances the bundling of cytoskeletal polymers of MreB and FtsZ, antagonizing the CbtA (YeeV) toxicity in Escherichia coli , 2012, Molecular microbiology.

[169]  M. Wainberg,et al.  Maraviroc and Other HIV-1 Entry Inhibitors Exhibit a Class-Specific Redistribution Effect That Results in Increased Extracellular Viral Load , 2012, Antimicrobial Agents and Chemotherapy.

[170]  A. Naura,et al.  The poly(ADP-ribose) polymerases (PARPs): new roles in intracellular transport. , 2012, Cellular signalling.

[171]  T. Wood,et al.  Toxin-Antitoxin Systems Influence Biofilm and Persister Cell Formation and the General Stress Response , 2011, Applied and Environmental Microbiology.

[172]  R. Koehler,et al.  Iduna protects the brain from glutamate excitotoxicity and stroke by interfering with poly(ADP-ribose) polymer-induced cell death , 2011, Nature Medicine.

[173]  Arjun Bhutkar,et al.  Poly(ADP-ribose) regulates stress responses and microRNA activity in the cytoplasm. , 2011, Molecular cell.

[174]  Raphaël Leplae,et al.  Diversity of bacterial type II toxin–antitoxin systems: a comprehensive search and functional analysis of novel families , 2011, Nucleic acids research.

[175]  V. Schreiber,et al.  Poly(ADP-ribose) polymerase 3 (PARP3), a newcomer in cellular response to DNA damage and mitotic progression , 2011, Proceedings of the National Academy of Sciences.

[176]  John M Denu,et al.  Identification of Macrodomain Proteins as Novel O-Acetyl-ADP-ribose Deacetylases* , 2011, The Journal of Biological Chemistry.

[177]  S. Lemire,et al.  Escherichia coli rnlA and rnlB Compose a Novel Toxin–Antitoxin System , 2011, Genetics.

[178]  Zixin Deng,et al.  TADB: a web-based resource for Type 2 toxin–antitoxin loci in bacteria and archaea , 2010, Nucleic Acids Res..

[179]  M. Schapira,et al.  Newly Discovered and Characterized Antivirulence Compounds Inhibit Bacterial Mono-ADP-Ribosyltransferase Toxins , 2010, Antimicrobial Agents and Chemotherapy.

[180]  Robert J. Fieldhouse,et al.  Cholera- and Anthrax-Like Toxins Are among Several New ADP-Ribosyltransferases , 2010, PLoS Comput. Biol..

[181]  W. Kraus,et al.  PARP-1 regulates chromatin structure and transcription through a KDM5B-dependent pathway. , 2010, Molecular cell.

[182]  Bernhard Lüscher,et al.  Toward a unified nomenclature for mammalian ADP-ribosyltransferases. , 2010, Trends in biochemical sciences.

[183]  T. Sugimura,et al.  Molecular cloning of apoptosis-inducing Pierisin-like proteins, from two species of white butterfly, Pieris melete and Aporia crataegi. , 2009, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[184]  L. Rice.  The clinical consequences of antimicrobial resistance. , 2009, Current opinion in microbiology.

[185]  S. West,et al.  Poly(ADP-ribose)–Dependent Regulation of DNA Repair by the Chromatin Remodeling Enzyme ALC1 , 2009, Science.

[186]  M. Högbom,et al.  Mechanism of ADP-ribosylation removal revealed by the structure and ligand complexes of the dimanganese mono-ADP-ribosylhydrolase DraG , 2009, Proceedings of the National Academy of Sciences.

[187]  Kathryn S. Lilley,et al.  The phage abortive infection system, ToxIN, functions as a protein–RNA toxin–antitoxin pair , 2009, Proceedings of the National Academy of Sciences.

[188]  A. R. Merrill,et al.  The nature and character of the transition state for the ADP‐ribosyltransferase reaction , 2008, EMBO reports.

[189]  R. Fieldhouse,et al.  Cholix Toxin, a Novel ADP-ribosylating Factor from Vibrio cholerae* , 2008, Journal of Biological Chemistry.

[190]  Emma Griffiths,et al.  Rifamycin antibiotic resistance by ADP-ribosylation: Structure and diversity of Arr , 2008, Proceedings of the National Academy of Sciences.

[191]  R. Magnuson.  Hypothetical Functions of Toxin-Antitoxin Systems , 2007, Journal of bacteriology.

[192]  G. Gao,et al.  The zinc-finger antiviral protein recruits the RNA processing exosome to degrade the target mRNA , 2007, Proceedings of the National Academy of Sciences.

[193]  K. Aktories,et al.  Bacillus sphaericus mosquitocidal toxin (MTX) and pierisin: the enigmatic offspring from the family of ADP‐ribosyltransferases , 2006, Molecular microbiology.

[194]  K. Acharya,et al.  A family of killer toxins , 2006, The FEBS journal.

[195]  T. Hill,et al.  Ectopic Overexpression of Wild-Type and Mutant hipA Genes in Escherichia coli: Effects on Macromolecular Synthesis and Persister Formation , 2006, Journal of bacteriology.

[196]  T. Mitchison,et al.  Tankyrase-1 polymerization of poly(ADP-ribose) is required for spindle structure and function , 2005, Nature Cell Biology.

[197]  K. Gerdes,et al.  Prokaryotic toxin–antitoxin stress response loci , 2005, Nature Reviews Microbiology.

[198]  E. Kremmer,et al.  PARP-10, a novel Myc-interacting protein with poly(ADP-ribose) polymerase activity, inhibits transformation , 2005, Oncogene.

[199]  A Rod Merrill,et al.  Structure-function analysis of water-soluble inhibitors of the catalytic domain of exotoxin A from Pseudomonas aeruginosa. , 2005, Biochemical Journal.

[200]  T. Sugimura,et al.  Mono(ADP-ribosyl)ation of DNA by apoptosis-inducing protein, pierisin. , 2002, Nucleic acids research. Supplement.

[201]  Yan Ma,et al.  Role of the Dinitrogenase Reductase Arginine 101 Residue in Dinitrogenase Reductase ADP-Ribosyltransferase Binding, NAD Binding, and Cleavage , 2001, Journal of bacteriology.

[202]  G. Poirier,et al.  Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. , 1999, The Biochemical journal.

[203]  A. Bogan,et al.  Anatomy of hot spots in protein interfaces. , 1998, Journal of molecular biology.

[204]  E. Dabbs,et al.  Ribosylative inactivation of rifampin by Mycobacterium smegmatis is a principal contributor to its low susceptibility to this antibiotic , 1997, Antimicrobial agents and chemotherapy.

[205]  J. Barbieri,et al.  The family of bacterial ADP-ribosylating exotoxins , 1995, Clinical microbiology reviews.

[206]  M. Couturier,et al.  Cell killing by the F plasmid CcdB protein involves poisoning of DNA-topoisomerase II complexes. , 1992, Journal of molecular biology.

[207]  K. Gerdes,et al.  Mechanism of postsegregational killing by the hok gene product of the parB system of plasmid R1 and its homology with the relF gene product of the E. coli relB operon. , 1986, The EMBO journal.

[208]  K. Ueda,et al.  ADP-ribosylation. , 2020, Annual review of biochemistry.

[209]  R. Collier,et al.  STUDIES ON THE MODE OF ACTION OF DIPHTHERIA TOXIN : I. PHOSPHORYLATED INTERMEDIATES IN NORMAL AND INTOXICATED HELA CELLS , 1964 .